Science | ABNewswire

Hemophilia Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Hemophilia Pipeline Insight, 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia pipeline therapeutics … Continue reading →

Pompe Disease Treatment Pipeline Shows Strong Momentum as 15+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Pompe Disease Pipeline Insight 2026” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Pompe Disease pipeline landscape. It covers the Pompe Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Prostate Cancer Clinical Trial Pipeline Expands as 140+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Prostate Cancer Pipeline Insight 2026” report provides comprehensive insights about 140+ companies and 150+ pipeline drugs in the Prostate Cancer pipeline landscape. It covers the Prostate Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Retinitis Pigmentosa Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Retinitis Pigmentosa Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in the Retinitis Pigmentosa pipeline landscape. It covers the Retinitis Pigmentosa Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Hearing Loss Clinical Trial Pipeline Gains Momentum: 30+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Hearing Loss Pipeline Insight 2026” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Hearing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Uveal Melanoma Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight

DelveInsight’s, “Uveal Melanoma Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Uveal Melanoma pipeline landscape. It covers the Uveal Melanoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Heartwell STAT Imaging Launches Rapid-Turnaround DVT Testing in Midtown New York City and New Jersey

Heartwell STAT Imaging was built on the principle that when your time matters as much as your health, you shouldn’t have to wait,” said Dr. Lara Oboler, founder and Medical Director of Heartwell. “We’re revolutionizing STAT accessibility for patients in … Continue reading →

Advanced Profile Wrapping Machine Technology Is Transforming Modern Furniture, Door, and Decorative Surface Manufacturing Processes

In today’s competitive manufacturing industry, companies are constantly searching for ways to improve production efficiency, product appearance, and long-term durability. One technology that has become increasingly important in the decoration and surface finishing sector is the profile wrapping machine. From … Continue reading →

Atomedge Highlights Early Contribution to Groundbreaking AR Anatomy Education Initiative

Atomedge’s advanced 3D Anatomy Model content is designed for integration into next-generation medical education, augmented reality, and immersive learning platforms. Atomedge highlights its early contribution to augmented reality anatomy education and its continued focus on advanced 3D Anatomy Model solutions … Continue reading →

Major Depressive Disorder Treatment Pipeline Shows Strong Momentum as 75+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Major Depressive Disorder Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the Major Depressive Disorder pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Thursday - May 28, 2026

Category Archives: Science